KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Prepaid Assets (2016 - 2026)

Biocryst Pharmaceuticals filings provide 16 years of Prepaid Assets readings, the most recent being $17.2 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 24.94% to $17.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.2 million, a 24.94% increase, with the full-year FY2025 number at $17.2 million, up 24.94% from a year prior.
  • Prepaid Assets hit $17.2 million in Q4 2025 for Biocryst Pharmaceuticals, up from $16.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $20.0 million in Q3 2023 to a low of $5.6 million in Q2 2021.
  • Median Prepaid Assets over the past 5 years was $13.9 million (2023), compared with a mean of $13.6 million.
  • Biggest five-year swings in Prepaid Assets: surged 108.75% in 2022 and later dropped 29.63% in 2024.
  • Biocryst Pharmaceuticals' Prepaid Assets stood at $10.0 million in 2021, then grew by 26.04% to $12.6 million in 2022, then surged by 55.27% to $19.5 million in 2023, then dropped by 29.63% to $13.8 million in 2024, then increased by 24.94% to $17.2 million in 2025.
  • The last three reported values for Prepaid Assets were $17.2 million (Q4 2025), $16.5 million (Q3 2025), and $12.5 million (Q2 2025) per Business Quant data.